1 | Order | 21 May 2005 |
10 | Hearing Notice | 09 Jul 2022 |
11 | Hearing Notice | 08 Aug 2022 |
12 | Hearing Notice | 14 Sep 2022 |
13 | Order | 19 Oct 2022 |
2 | Assignment Deed | 09 Nov 2005 |
2 | Authorization Document (POA) | 09 Nov 2005 |
3 | Assignment Deed | 09 Nov 2005 |
3 | Authorization Document (POA) | 09 Nov 2005 |
4 | TM-16 | 27 Mar 2006 |
5 | Power of Attorney | 23 Apr 2014 |
5 | TM-16 | 23 Apr 2014 |
6 | Covering Letter | 23 Apr 2014 |
7 | Power of Attorney | 23 Apr 2014 |
7 | TM-16 | 23 Apr 2014 |
8 | TM-16 | 15 Mar 2016 |
9 | Letter | 17 Aug 2017 |
The application for Prestozyme was made on 18 December 2001.
The trademark applicant for Prestozyme is ENDOVEN PHARMACEUTICAL.
Prestozyme is applied in class(es) 5.
Application for Prestozyme is on Abandoned stage.
Application Id allotted to Prestozyme is 1067213.
Trademark agent or attorney for the application is Aditya & Associates.
Prestozyme filed with the Intellectual property office as a WORD.